GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Total Inventories

Minapharm Pharmaceuticals (CAI:MIPH) Total Inventories : E£1,276 Mil (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Total Inventories?

Minapharm Pharmaceuticals's total inventories for the quarter that ended in Sep. 2024 was E£1,276 Mil. Minapharm Pharmaceuticals's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Sep. 2024 was E£1,272 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Minapharm Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was E£-511.49.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Minapharm Pharmaceuticals's Days Inventory for the three months ended in Sep. 2024 was 124.17.

Inventory Turnover measures how fast the company turns over its inventory within a year. Minapharm Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.73.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Minapharm Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.84.


Minapharm Pharmaceuticals Total Inventories Historical Data

The historical data trend for Minapharm Pharmaceuticals's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Total Inventories Chart

Minapharm Pharmaceuticals Annual Data
Trend Dec22 Dec23
Total Inventories
838.28 1,054.99

Minapharm Pharmaceuticals Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Total Inventories Get a 7-Day Free Trial - - 1,054.99 1,267.87 1,275.91

Minapharm Pharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Minapharm Pharmaceuticals  (CAI:MIPH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Minapharm Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is

Net-Net Working Capital Per Share (Q: Sep. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(231.086+0.75 * 464.34+0.5 * 1275.909-7381.744
-0-123.244)/12.293
=-511.49

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Minapharm Pharmaceuticals's Days Inventory for the three months ended in Sep. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2024 )/Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=1271.8905/934.719*365 / 4
=124.17

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Minapharm Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2024 ) / Average Total Inventories (Q: Sep. 2024 )
=934.719 / 1271.8905
=0.73

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Minapharm Pharmaceuticals's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=1271.8905 / 1512.966
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Minapharm Pharmaceuticals Total Inventories Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Minapharm Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY
Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines